FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea, expanding use in U.S.

FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea, expanding use in U.S.

An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March 28, 2024.  Shelby Knowles | Bloomberg | Getty Images The Food and Drug Administration approved Eli Lilly‘s blockbuster weight loss drug Zepbound for treating patients with the most common sleep-related breathing disorder, the drugmaker announced…

Read More
Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says

Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says

A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk.  Reuters Prescription fills for blockbuster weight loss drugs in the U.S. more than doubled in 2024, even with limited insurance coverage and high out-of-pocket costs for the treatments, according to data released Thursday…

Read More